Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID Guides to $3M-$6M in Revenues for 2015

NEW YORK (GenomeWeb) – Biological detection systems firm PositiveID today issued revenue guidance of between $3 million and $6 million for 2015.

The company said that in 2014 it recorded its first revenue since launching its molecular diagnostics business in 2011 and reported total revenue of $745,000 for the first nine months of 2014. PositiveID Chairman and CEO William Caragol added in a statement that the firm has a "significant backlog and pipeline of revenue opportunities for 2015 and beyond. In the short term, these opportunities are primarily based on a signed license agreement with a major commercial partner, government programs for operational testing and evaluation of M-BAND, and the further development of Firefly Dx." 

The M-BAND system for detecting biological agent attacks was developed under contract with the US Department of Homeland Security, Science & Technology directorate and included $30 million in contract funding. 

Firefly Dx is a PCR-based technology being developed for rapid and accurate point-of-need diagnostics and is targeted to hospitals, first responders, and other providers, PositiveID said. 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.